Evidence map›Paper›PMID 40302048›Full record

Observational studyPhysical therapy2025

Physical Function Differences by COVID-19 Status: A Cross-sectional Analysis From the RECOVER Adult Cohort.

Grace L Kulik, Tianyu Zheng, Sarah E Jolley, Hassan Ashktorab, Hassan Brim, Elen M Feuerriegel, John W Hafner, Rachel Hess, Benjamin D Horne, Mady Hornig and 13 more

Registry-linked trialAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Physical therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05172024 (NIH RECOVER), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05172024 completednot on this map

NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults

TypeobservationalSponsorNYU Langone HealthRan2021 to 2025Enrolled15,172ConditionsSARS-CoV2 Infection
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Grace L KulikDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
Tianyu ZhengPopulation Health Sciences Department, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT 84112 , United States.
Sarah E JolleyDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
Hassan AshktorabDepartment of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Hassan BrimDepartment of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Elen M FeuerriegelDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
John W HafnerDepartment of Emergency Medicine, University of Illinois College of Medicine, Peoria, IL 61605, United States.
Rachel HessPopulation Health Sciences Department, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT 84112 , United States.
Benjamin D HorneIntermountain Heart Institute, Intermountain Health, Salt Lake City, UT 84111, United States.
Mady HornigDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY 10032, United States.
Brandon JohnsonDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
C KimRECOVER Patient, Caregiver, or Community Advocate Representative, New York, NY 10012, United States.
Adeyinka O LaiyemoDepartment of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Grace A McComseyDepartment of Medicine, Case Western Reserve University, Cleveland, OH 44106, United States.
Janko Ž NikolichAegis Consortium for Pandemic-free Future and Department of Immunobiology, University of Arizona Health Sciences, Tucson, AZ 85724, United States.
Kayleigh ReidDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
John ScherryBeth Israel Deaconess Medical Center, Boston, MA 02215, United States.
Zaki A SherifDepartment of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Huong G TranDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
Monica Verduzco-GutierrezDepartment of Rehabilitation Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, United States.
Shelby WestDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
Kristine M ErlandsonDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
RECOVER Adult Cohort Consortium

Funding

ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating CenterOT2HL156812 · NHLBI · RESEARCH TRIANGLE INSTITUTE · PI NOLEN, TRACY L, THOMAS, SONIA M · 2020 to 2024
$1270.7M
OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository CoreOT2HL161847 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GROSS, RACHEL SHARON, HORWITZ, LEORA · 2021 to 2025
$651.0M
Interactive Data Portals and Robust Analytic Tools to Wrap PASC Cohorts (iDRAW) OTA-21-015AOT2HL161841 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI FOULKES, ANDREA S, KARLSON, ELIZABETH W · 2021 to 2024
$182.2M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages to Equity in Health (CLE Health)UM1TR004528 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI GRACE A MCCOMSEY · 2023 to 2026
$32.1M
Colorado Clinical and Translational Sciences Institute (CCTSI)UM1TR004399 · NCATS · UNIVERSITY OF COLORADO DENVER · PI JANINE A HIGGINS, RONALD J. SOKOL · 2023 to 2026
$30.7M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Training Program for Antiretroviral Discovery, Evaluation and Application Research (ADEAR)T32AI150547 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Joshua Adam Barocas, Kristine Mace Erlandson · 2020 to 2026
$1.3M
Mentoring Across Disciplines: Aging and Infectious Diseases with a Focus on MobilityK24AG082527 · NIA · UNIVERSITY OF COLORADO DENVER · PI Kristine Mace Erlandson · 2023 to 2026
$768k
National Center for Advancing Translational Sciences component of the NIH UM1TR002548NCATS NIH HHS UL1 TR002548NCATS NIH HHS UM1 TR004399NCATS NIH HHS UM1 TR004409NCATS NIH HHS UM1 TR004528NHLBI NIH HHS OT2 HL156812NHLBI NIH HHS OT2 HL161841NHLBI NIH HHS OT2 HL161847NIAID NIH HHS T32 AI150547NIA NIH HHS K24 AG082527NIH HHS OT2HL156812NIH HHS OT2HL161841NIH HHS OT2HL161847University of Arizona Strategic InitiativesUtah Clinical and Translation Science Award UM1TR004409
6 · The paper itself

Abstract

importanceMany adults with prior SARS-CoV-2 infection have persistent limitations, but few studies have examined objective physical function impairment that persist longer than 3 months after infection.

objectiveThe objective was to characterize physical function impairment among adults with and without SARS-CoV-2 infection.

designThis study was a retrospective, cross-sectional analysis.

settingResearching COVID to Enhance Recovery (RECOVER) initiative, a multi-site observational study in the United States (ClinicalTrials.gov: NCT05172024).

participantsParticipants were adults ≥18 years old with and without SARS-CoV-2 infection. EXPOSURES: Groups were defined based on COVID-19 status at enrollment: never diagnosed (control), diagnosed with COVID-19 ≤ 12 weeks (recent COVID-19), or > 12 weeks prior to enrollment (remote COVID-19). The RECOVER-Adult Long COVID Index was used to further characterize by Index ≥12 versus 0. MAIN OUTCOMES/MEASURES: Physical function (main outcome) was assessed by number of repetitions on a 30-second sit-to-stand test (30STS).

results30STS assessments at enrollment were available from 11,578 participants. 30STS repetitions were lowest in the remote COVID-19 group (n = 4942) with 11.5 (SD = 4.2) repetitions compared to 12.5 (SD = 4.7) repetitions among controls (n = 1887) or 12.2 (SD = 4.5) in recent COVID-19 (n = 4698). Remote COVID-19, but not recent COVID-19, was associated with lower physical function in the adjusted model (-0.61 repetitions; SD = 0.21). Those with RECOVER Long COVID Research Index ≥12 performed 1.6 (SD = 0.2) fewer repetitions than those with an Index equal 0.

conclusionsPhysical function impairment did not show clinically meaningful group differences between RECOVER Adult Cohort participants by COVID-19 status, or by Long COVID Index. Individual responses over time or in response to an intervention may be more clinically relevant. RELEVANCE: In the RECOVER adult cohort, overall physical function differences by time since COVID-19 or by Long COVID Index were small. Individualized assessments are needed to determine functional impairment following COVID-19 diagnosis and subsequent steps for rehabilitation interventions.

Indexed as

COVID-19Physical Functional PerformanceAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesSARS-CoV-2United StatesCovid-19Long CovidPASCPhysical Function

Identifiers

PMID40302048
PMCPMC12212418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.